Maataloustieteellinen A ikakauskirja Vol. 61: 405—414, 1989 Legal protection of plant biotechnological inventions P.T. VANHALA, T. PEHU, H.G. GYLLENBERG Department of Microbiology, University of Helsinki, SF 00710 Helsinki, Finland Abstract. Within biotechnology, plant production is regarded as one of the most promising adaptations. New plant breeding methods are considered to better fulfil the requirements set on patentability than the traditional breeding methods. In Europe, a plant variety can be pro- tected by special legislation. The present patent laws in Europe are not applied to plant biotechnological inventions. The United States has three systems under which new varieties of plants may be protected. These include The 1930 Plant Patent Act, The 1970 Plant Variety Protection Act and The 1952 Patent Statute. Companies that have specialized in plant breed- ing and organizations representing the industrial countries recommend improvements to the legal protection. On the other hand, farmers and the developing countries are against better protection. Index words: plant patent, breeder’s rights I. Introduction Within biotechnology, plant production is regarded as one of the most promising adap- tations. Today, several types of biotechnolog- ical breeding methods are used in plant breed- ing. These new methods are considered to ful- fil better the requirements set on patentabili- ty than the traditional breeding methods. Against this background, extension of the pat- ent protection to cover also new plant varie- ties has become a topic of current interest. Be- cause of the fast development of biotechno- logical breeding methods it has become neces- sary to apply patent legislation in a very flex- ible way all over the world. The trend seems to continue also in the future. Therefore, is- sues on legal protection of plant breeding methods are relatively problematic to deal with. The purpose of this study is to review the current legal state of the plant breeder’s rights and patent legislation in Western Europe and in the United States. The first part of the study examines international agreements and na- tional patent laws, the second part the need to further develop the legal rights from the viewpoints of different interest groups. 405 JOURNAL OF AGRICULTURAL SCIENCE IN FINLAND https://www.c-info.fi/en/info/?token=7Z8QnfAqGauc3DF6.UECO4B3VBumCNY0jesUZ1Q.em-uSDRWE_ksMRKbgKKuFcQBn9Yn1JznwSXv_7dW7jcrz26TzZqNrVuqvX3ZpuMTqBxmONFsOrZRLyxLBxZ5qQIt6aZy7OLCOl4DgprVQT7dJfv4m0spzrj_UI-NSQem2dwmnE9uKnYSkGkIMTlb1sK0O65kSLqKcCP980pf6SkThK6OhMxowRkKb9Vo7zDyIP_QwQ The study is a review of literature collected from databanks (Dialog and Dimdi), interna- tional agreements and other juridical publica- tions. 2. The protection of plant varieties in international agreements 2.1. The Strasbourg Convention Unification of European patent laws was started in the late 19505. Due to the problematic nature of the task, questions con- cerning the patenting of plant varieties were not discussed at the conference (Beier and Straus 1986). The negotiations led to the Strasbourg Convention which was signed in 1963. Article 2 of the Convention statute: “The Contracting States shall not be re- quired to grant patents for: a. b. Plant or animal varieties or essentially bi- ological processes for production of plants or animals; this provision does not apply to microbiological processes or the products thereof.” This article has had great significance on the patent protection of plant varieties, since it has been transferred as such to the European Patent Convention of 1973, appearing there as Article 53. Furthermore, the countries par- ticipating in the European Patent Convention have adopted this article in the same or essen- tially the same form in their national patent laws. 2.2. The UPOV Convention When the inapplicability of patenting for plant variety protection was recognized, a new protection procedure was created for that pur- pose. It was signed as the UPOV Convention (UNION POUR LA PROTECTION DES OBTENTIONS VEGETATES) in 1961. This convention aims to recognize and to secure the breeder’s rights regarding a new plant variety (Article 1). Each contracting state guarantees thebreeder’s rights by grant- ing a special title of protection (Article 2). The holder of the privilege possesses the monopoly of commercial production, supply and trade of propagation material. The term “propagation material” covers, by definition, the entire plant (Article 5). Because the pro- tection applies to propagation material, it does not cover other uses of plant material or har- vest. The convention permits the production of propagation material for the farmer’s own needs. The plant variety, for which protection is sought, should be distinguishable from previ- ously known varieties, both morphologically and physiologically. The variety should be sufficiently homogeneous and stable in its es- sential characteristics through repeated propa- gation cycles (Article 6). In principle, the breeder’s rights can be ap- plied to all botanical genera and species (Ar- ticle 4). Yet, due to the shortness of resources for the study of varieties, each decides in- dependently whether or not a new plant fam- ily will be included within the scope of pro- tection. Further breeding of the protected va- riety is permitted, as is the case with commer- cial utilization of its results (Article 5). It is decreed by Article 2 of the Convention that a contracting state may protect a variety of a certain family or species, either by a pat- ent or by the breeder’s rights, but not by both. With the membership of the United States in 1978 Article 37 was included in the Conven- tion. This article permits double protection in instances where both forms of protection have been granted before a state has joined the Convention, which was the case with the United States. 2.3. The European Patent Convention (EPC) 2.3.1. Patentability Articles 52 and 83 of the European Patent Convention present a list of criteria of patent- ability of an invention (Anon. 1981). 406 These are as follows: 1. inventive step 2. industrial application 3. novelty 4. repeatability Clause 2 in Article 52 determines the in- stances when patents cannot be granted. These are either abstract or non-technical by charac- ter. According to the GUIDELINES FOR EXAMINATION IN THE EPO (European Patent Organisation) 1987, Article 52 pre- sumes an invention to be both concrete and technical by nature (Anon 1985). A plant va- riety does not meet these criteria because it is difficult to encompass the concept of variety into a concrete definition. In the case of plant material, however, this kind of definition is possible. In versely, the concepts of plant va- riety and plant material are difficult to con- ceive as technical by nature. According to Article 57, an invention must be considered as susceptible of industrial ap- plication if it can be made or used in any kind of industry, including agriculture. The Guide- lines of the EPO suggest that “industry” should be understood in a broad sense. The requirement of repeatability is pre- sented in Article 83. It states that an inven- tion can be carried out by the person skilled in the art on the basis of the patent applica- tion. As for plant varieties or plant material, the requirement of repeatability can be met by a deposit practice defined in the Budapest Treaty. This treaty concerns the international acknowledgement of the micro-organism de- posit practice. The EPC decrees that a pa- tented micro-organism must be deposited in an internationally acknowledged deposit in- stitute(EPC RULE 28). Some institutes have agreed on the acceptance of plant cell culti- vations and seeds to be deposited as micro- organism (Anon. 1986). Article 53a excludes from patent protection inventions which could be contrary to “ordre public” or morality. By the correct interpre- tation of this point the granting of ethically questionable patents can be prevented. Article 53b excludes from patent protection plant varieties and essentially biological processes used for the production of plants. The greatest controversy of patent protection of plants rises from this point. Because Arti- cle 53b uses the two concepts of plant and plant variety, they must be regarded as dif- ferent in bearing (Lommi 1987a). 2.3.2. Plant variety The rule of excluding plant varieties from patent protection conforms with the prereq- uisites of patentability, because the concept of plant variety lacks a precise definition. A plant variety is generally defined on the basis of three features, i.e. distinguishability, unifor- mity and stability. In the decision known as T49/83 CIBA GEIGY the Technical Board of the Appeals of the EPO defines the distinc- tion between plant variety and other plant ma- terial. Thereby a plant variety is “a multiplic- ity of plants which are largely the same in their characteristics and remain the same within specific tolerances after every propagation or every propagation cycle”. Experts in this field tend to support the patentability of plants on condition that this claim does not directly concern plant varieties. In its decision (T49/83 CIBA GEIGY) the Eu- ropean Patent Office made a statement that the items excluded from patent protection are plant varieties solely, not plants in general. The decision was made in association the EP Application 10588, where the following claims were presented: “Claim 13: Propagating material for culti- vated plants, created with an oxime derivative according to Formula 1 in Claim 1. Claim 14: Propagation material according to Claim 13, characterized in that it consists of seed.” It was decreed in the decision that propa- gation material treated with a chemical is patentable with the restriction that the claim does not concern a spectic plant variety. 407 2.3.3. The essentially biological process The EPC denies patent protection for the essentially biological processes used for the production of plants. It is to be noted that in this context the term plant is used instead of plant variety. This leads to the conclusion that the rule which denies patent protection for plant varieties does not cover plants in gen- eral. The essentially technical processes of plant production are patentable. In the Guidelines for Examination in the EPO, the essentially biological and the essentially technical processes are delineated. According to the guidelines, the amount of technical interven- tion by man is adecisive factor. If such inter- vention plays a significant role in the outcome, the process would not be excluded. Thereby, a process of treating a plant to improve its properties or to improve its growth, e.g. a method of prunning a tree, would not be an essentially biological process. Although a biological process is involved, the essence of the invention is technical. The classical breeding methods based on crossbreeding and selection cannot, according to the instructions, be patented, whereas those using biotechnical processes are patentable since all these procedures require technical in- tervention by man. Similarly, most of these processes can be classified as chemical. 2.3.4. The microbiological method According to the EPC, a patent can be granted to a microbiological process or the products thereof. Biotechnical plant breeding processes are either macro- or microbiologi- cal by nature, and it is not easy to distinguish between the two. The problems of distinction can be illustrated by the EP Application 122791 in which claims are presented for: a DNA shuttle vector comprising T- DNA... a method for genetically modifying plant ce11... a plant, a plant tissue, or a plant cell produced according to the claimed meth- od. Both the national patent laws and the in- ternational agreements have been avoiding the definition of the term micro-organism. In the international patent classification (C 12, Note 2) items such as viruses, undifferentiated plant and animal cells and protozoa are also in- cluded in the concept of micro-organism (Anon 1985). In The Guidelines for Exami- nation in the EPO, microbiological processes include in addition to technical processes us- ing micro-organisms also processes for the production of new micro-organisms, e.g. gene technological processes. The absence of defi- nition of the terminology from patent legis- lation has led to the practice of using the term “microbiological process” to signify the DNA-techniques and protoplast fusions alongside with microinjections and other gene technological processes (Beier and Straus 1986). 3. Plant variety protection in national patent laws 3.1. The United States The United States has three systems under which new varieties of plants may be pro- tected: The 1930 Plant Patent Act (PPA) The 1970 Plant Variety Protection Act (PVPA) The 1952 Patent Statute The Plant Patent Act (PPA) (35 USC 161 164) The PPA grants patent protection for asex- ually propagated plant varieties (Sec. 161). The Act was confined to asexual propagation only, because at that time it was believed ade- quate uniformity and stability can be main- tainedonly by this reproduction method. Pa- tents are also granted for discoveries that are made from the uncultivated state. 408 The requirements of the PPA concerning novelties and distinction are in conformity with the General Patent Statute. However, Sec. 162 decrees that, as to description, the requirements of Sec. 112 do not cover plant patent applications. A description of the va- riety as complete as is reasonable is consid- ered sufficient. Deposit of propagation ma- terial is not required. The application cannot contain more than one claim, which should concern the variety to be patented (Sec. 162). A granted plant patent prohibits others from asexually reproducing the plant. The number of granted plant patents rises to about 6000 at present, with an increase of about 400 patents per year (Van Horn 1987). The Plant Variety Protection Act (PVPA) (7 USC 2321—2583) Growing interest in the protection of plant varieties propagated from seeds led to the enactment of the Plant Variety Protection Act in 1970. This Act provides protection similar to the patent protection for sexually propa- gated plant varieties. With the entrance of the USA into the UPOV Convention in 1980, this was amended to conform with the UPOV. The plant breeder’s rights have now been granted for about 2000 plant varieties in the USA, while the number of new cases is about 200 per year (Van Horn 1987). The Patent Statute (35 USC 101) The United States’ Patent Statute decrees, in Clause 101, that patent protection can be granted for any new and useful process, ma- chine, manufacture, or composition of mat- ter, or any useful improvement thereof. No industrial application of the invention is not required, nor is its technical character empha- sized the way it is in Europe. A patent case EX PARTE HIBBERD 1985 extended the General Patent Statute to cover also plant varieties that are subject to the PVPA. The item discussed was a variety of maize which produced high quantities of tryp- tophan. Cell lines with high quantities of tryp- tophan were selected and regenerated into whole plants. The claims were made for seeds, cell lines and plants (Hibbertd 1985). The claim concerning the plant was as follows: Claim 249: “A maize plant capable of producing seed having an endogenous free tryptophan content of at least about one-tenth milligram per gram dry seed weight, wherein the seed is capable of germination into a plant capable of producing seed having an en- dogenous tryptophan content of at least about one-tenth milligram per gram dry seed weight.” It was decided in the course of the process that, although this invention belongs within the scope of the PVPA, normal patenting practice may be applied. Consequently, a patent was granted to this invention (US 4581847). 3.2. The nationalpatent laws in Europe The Strasbourg Convention, which took shape through negotiations on the conformi- ty of patent legislation, did not exclude plant varieties from patent protection. Instead, it left the matter to be decided in each country separately. Among the contracting states, FRG, France, Belgium and Spain have decid- ed for the patentability of plant varieties that are not included in their national legislation on breeder’s rights (Straus 1987). Conse- quently, patents have been granted in West Germany for the hybrid to tomato and pota- to (DE 2842197) and for the tetraploid camo- mile (DE 3423207). The definitions of patentable inventions are uniform in the Scandinavian patent legislation on the lines included in the Strasbourg Con- vention. The Scandinavian countries act in ac- cordance with the patenting practices of the EPO, amending their decrees only when the decrees of the EPC are amended (Lommi 1987b). Finland and Norway are in principle more free to interpret of the present patent legisla- tion, because they have not signed the UPOV Convention. In this case, plants appear to be patentable, presuming that they meet the other 409 requirements of patentability and are not clas- sified as plant varieties (Hjelt 1987). 4. The need to improve plant variety protection 4.1 The plant breeder’s viewpoint Plant breeders using the traditional breed- ing methods appear to be satisfied with the breeder’s rights and the protection provided by them. The right to further breed is partic- ularly emphasized by the breeders. The attitude of small breeding companies is cautiously positive towards improving the plant variety protection by patenting. A pat- ent would provide better protection than the breeder’s rights. By a single application, pat- ent protection can be sought for several differ- ent varieties and parts of plants. Moreover, it is less costly to apply for a patent than for breeder’s rights, at least in the United States (Lesser 1986a). Statistics from 1980 show that in the United States the number of new wheat, soybean and cotton varieties introduced annually was 3—6 times higher after the enforcement of the breeder’s rights than before (Berland and Lewontin 1986). Private investment in plant breeding was also tripled in ten years since 1970, the year of enforcementof the breeder’s rights (Barton 1982). Hence, the number of new plant varieties launched to the market will be augmented with the protection of varieties. Yet, the real value of breeding work cannot be estimated by this fact, because the varie- ties introduced by private companies tend to resemble each other closely in their charac- teristics. Plant breeders fear that such cos- metic breeding would increase if patents are granted for plant varieties. Judging by the ef- fects of the breeder’s rights, this is to be ex- pected (Lesser 1986b). The patenting of plant varieties would pre- vent the free use of a protected variety for plant breeding. Breeders using the traditional methods stand for the viewpoint that plant varieties should remain free for utilization in plant breeding, regardless of the methods by which they have been produced (Masten- broek 1985). According to this view, a certain gene, for example, could be patented, but when transferred into a plant, patent protec- tion no longer would be applicable (Dickson 1985). A more positive view in the question of patentability of plant varieties is taken by those breeders who apply biotechnological breeding methods. They claim that the special characteristics of the biotechnological breed- ing methods are not adequately appreciated in the protection policy based on the breed- er’s rights. This is due to the fact that, at the time the breeder’s rights were enacted, these techniques were not known. Breeders find it unjust that the results of the work demand- ing great investment should remain free for any utilization. For example, when plant va- riety with a certain resistance is developed, protection is sought for all varieties produced by the same invention, i.e. the gene causing the resistance. However, this protection can- not be provided by the breeder’s rights. In most countries where the legal position of plant breeders has been improved, plant breeding is mostly practiced by private com- panies. The patenting of plant varieties would lead to the disappearance of unprotected var- ieties from the market. It is suspected that varieties created by public means might even- tually fall into private patenting (Barton 1982). It is an alarming prospect for plant breeders that the generalization of biotechno- logical breeding methods, together with the tightening protection of plant varieties, might lead to the concentration of all plant breed- ing activity into the hands of large companies (Dickson 1985). The improved protection has benefithed plant breeding companies. Private breeding activity in England had met with several difficulties before the enforcement of the law that guaranteed the breeder’s rights (Barton 1982). Previously the Government had a ma- jor role in the breeding activity, but the law 410 411 has resulted in a significant rise in private breeding activity (Aro 1977). 4.2. The seed producer’s viewpoint It is necessary for the seed company to pro- duce seed of adequate quality at lower costs than the farmer does or, alternatively, prevent the farmer from using his own harvest as seed. This can be done by producing sterile seed in the manner of the hybrid varieties, or by patenting the seed. The absence of patent pro- tection has partly contributed to the great rise in the use of hybrid varieties (Berland and Lewontin 1986). Plant breeding and seed production usual- ly take place in separate institutes. Where the breeder’s rights are applied, the seed producer is obliged to pay royalties to the breeder for the right to utilize the variety. These costs are transferred to the seed price, to be paid by the farmer. However, the market price of the seed must not exceed the limit after which it be- comes more profitable for the farmer to pro- duce seed for his own needs. After the enforcement of the breeder’s rights in England, many seed producers went bankrupt. The new law forced them to raise seed prices, which caused them difficulties in marketing the seed. Seed companies tried to evade the law by producing seed from the farmers own harvests, leaving the breeders without royalties. Plant breeders have made efforts to prevent this. In France, for instance, plant breeders managed in 1985 to enforce a law prohibiting this kind of activity (Berland and Lewontin 1986). Seed producers are generally in favor of the extension of patent protection to cover also plant varieties. The American Seed Trade As- sociation (ASTA) supports the patenting of plants. It also supports the simultaneous ap- plication of patenting and breeder’s rights (Murphy 1987). Patenting is supported by the argument that it would prevent farmers from using their own harvest as seed. This, again, would accelerate the introduction of new varieties and promote breeding activity. The concentration of seed production into a few large companies is a prevailing trend in the USA. In 1980, the large breeding compa- nies were responsible only for 20 % of all pat- ent applications concerning plants, but now an increasing number of small companies are being fused into large ones (Barton 1982). Yet, it is difficult to show whether this is due to general industrial trends or to the improved protection of plant varieties. Companies that have actively invested in plant biotechnology are increasingly purchas- ing seed companies as a means of effectively launching new varieties to the market (Rosenqvist et ai. 1987). The heavy invest- ments give special weight to the demand for protection. In the United States, large seed companies have presented these demands for several years already (Lesser 1986a). The present European legislation seems to be in- adequate especially for the protection of plant varieties. Companies applying biotechnological processes stand for the view that the breed- er’s rights do not in any circumstances pro- vide adequate protection for plant varieties in the field of biotechnology. The breeder’s rights are only applicable to the traditional breeding techniques for which they were origi- nally designed. The companies claim theright to decide independently on the form of pro- tection. Special dissatisfaction is aroused by the right for further breeding, because a mo- nopoly could easily be evaded by insignificant amendments in a variety. 5.3. The farmer’s viewpoint Facing the improving variety protection, farmers are concerned about the rising seed prices. There is also the fear of the number of cultivated plant varieties to reduce as a con- sequence of the protection. Large homogene- ous monocultures are especially vulnerable to crop damage. The patenting arrangement would cause an empoverishment in the choice of varieties through the concentration of seed production. This process leads to the loss of valuable genetic material through the disap- pearance of old varieties (Bell 1985). 4.4. The international situation 4.4.1. The industrial countries’ viewpoint The OECD report, BIOTECHNOLOGY AND PATENT PROTECTION 1985, sup- ports the improvement of plant variety pro- tection by patenting. The report exhorts governments to seek possibilities for better protection of plants produced by the gene technological methods. It is further proposed that breeders be given the right to choose the form of protection between patenting and breeder’s rights. The WORLD INTELLECTUAL PROP- ERTY ORGANIZATION (WIPO) has de- lineated the present situation of protection policies within the field of biotechnical inven- tions. The results have motivated a list of pos- sible solutions for the ambiguous points. Thereby: all biotechnological inventions should be considered patentable, the patenting of plants should be possible at least as far as plant varieties are not con- cerned, and the protection of living material should cover subsequent generations, too (Anon. 1985). 4.4.2. The developing countries’ viewpoint There has been strong criticism on the part of the developing countries against plant va- riety protection, in fear that it may promote the monopoly of multinational companies on food production (Dixon 1985). The UNITED NATIONS FOOD AND AGRICULTURAL ORGANIZATION (FAO) presents the viewpoint that seeds, along with other plant material, are a common heritage of mankind, and should thus be exploitable by anyone. The enforcement of patent pro- tection is assumed to reduce breeding activity funded by public means which is the form of breeding activity that has the greatest bearing for the developing countries. 5. Results and conclusions In the United States, where it is possible to protect a plant with a patent or the breeder’s rights, the patent law is better adapted to the development of biotechnology than in Eu- rope. As far as EPC is concerned, the patent legislation still seems to be relatively unsettled. The reformation process of legislation appears to be so slow that, in the present situation, the interpretation of the law has to be as flexible as possible. Efforts have been made to improve the patent protection of plant by a new interpre- tation of such legal expressions as “a plant va- riety”, “a microbiological method” and “an essentially biological method”. For the mo- ment, plant material can be regarded patent- able but, on the other hand, there are no precedents to clarify the matter. There are no signs of a reform of the EPC in the near fu- ture. However, it is most evident that the patenting of plants will become possible either by reinterpretation of the law or after amend- ments. The greatest weaknesses of the plant varie- ty protection provided by the UPOV seam to be the right to further breed protected plant varieties and the farmer’s right to use his own harvest as seed. It is evident that the number of UPOV members will not increase in the fu- ture unless the protection provided by the Convention is improved. With increasing plant patenting the importance of the UPOV will diminish. Two interest groups can be recognized: companies specializing in plant breeding and organizations representing the industrial coun- tries. They both recommend improvements to the legal protection and stand for the libera- tion of plant patenting. The improved protec- tion is assumed to speed up research as it in- creases the willingness to invest in plant breed- ing. 412 On the other hand, farmers in industrial countries and the developing countries are against the improvements of the plant breed- ers’ legal rights. Farmers fear for an increase in seed prices as well as for too much depen- dence on the producer. The developing coun- tries also feel suspicious about the multina- tional seed companies whose influence is ex- pected to increase if plant patenting is made possible. Acknowledgements. The authors are most grateful to Ms Hely Lommi, The National Board of Patents and Registration, for critical reading of the manuscript and valuable comments and advice, as well as to Ms Sisko Knuth-Lehtola, ALKO Ltd, Helsinki, Finland, for con- sultation. 6. References Anon, 1981. European Patent Convention. European Patent Office. 2nd Ed. Wila Verlag, Wilhelm Lampi. Miinchen. 328 p. 1984. International Patent Classification. 4th Ed. Vol- ume 3. World Intellectual Property Organization. Carl Heymanns Verlag KG. Miinchen. 1985. Guidelines for the Examination in the EPO. Guidelines for substantiv examination. Part C, Chap- ter 4.3.5. 1986. Industrial property protection of biotechnolog- ical inventions. Industrial Property. 25(6) 253—274. Aro, P.L. 1977. Kasvinjalostajan oikeudellisesta asemas- ta. Suomen lakimiesyhdistyksen julkaisusarja, A 119, Vammalan Kirjapaino Oy, Vammala. 135 s. Barton, J. 1982. The International Breeder’s Rights Sys- tem and Crop Plant Innovation. Science 216(4) 1071 1075. Beier, F. & Straus, J. 1986. Genetic Engineering and In- dustrial Property. Industrial Property 86(11), 447—459. Bell, R. 1985. Case Against Plant Patenting. Search 16, 9—12. Beri and, J. & Lewontin, R. 1986. Breeder’s Rights and Patenting life forms. Nature 322, 785—787. Dickson, D. 1985. Chemical Giants Push for Patents on Plants. Science 228, 277—280. Dixon, B. 1985. Debate over plant patents grow in Eu- rope. Biotechnology 3, 855. Hibberd 1985. USA, Board of Patent Appeals and In- terferences of the United States Patent and Trademark Office. 227 USPQ 443. Hjelt, P. 1987. Patentoitavuus. Kemian jabiotekniikan patenttikysymykset, INSKO 9—lo. 12. Lesser, W. 1986a. Patenting Seeds in the United States of America: What to Expect. Industrial Property 9, 49—57. Lesser, W. 1986b. Seed Patent Forecast. Biotechnology 4, 783. Lommi, H. 1987a. Miten Suomen patenttijärjestelmä soveltuu kasvi- jaeläinkeksintöjen suojaamiseen. Ke- mian ja biotekniikan patenttikysymykset, INSKO, 9.—10. 12. —1987 b, Selostus biotekniikan alan keksintöjen suojamuotoja käsittelevän asiantuntijakomitean ko- kouksesta Genevessä 29. 6—3. 7.1987. 5 p. Mastenbroek, C. 1985. Plant breeder’s rights and pat- ent protection in relation to new developments in plant breeding. Zaadbelangen 4, 10—15. Murphy, C. 1987. National Board Debates Impact of Biotech Patents on Germplasm. Diversity 11, 10. Rosenqvist, H., Seppänen, P. & Törmälä, T. 1987. Kas- vibiotekniikan mahdollisuudet biotekniikassa. Kemia- Kerni 14(3), 225—228. Straus, J. 1987. Personal communication. Kemian ja biotekniikan patenttikysymykset, INSKO 9.—10. 12. Van Horn, C. 1987. Recent developments in the patent- ing of the biotechnology in the United States. Sym- posium on the protection on the biotechnological in- ventions. Ithaca, New York. 73 —75. Ms received March 20, 1989 413 SELOSTUS Kasvibiotekniikan oikeudellinen suoja P.T. Vanhala, T. Pehu, H.G. Gyllenberg Helsingin yliopisto. Mikrobiologian laitos Keksinnön on täytettävä tietyt ehdot, jotta se voidaan patentoida. Patenttilain soveltamista kasveihin rajoittaa perussääntö, jonkamukaan keksinnön tulee ollasillä ta- valla kuvattu, että asiantuntija voi kuvauksen perusteel- la toistaa keksinnön. Nykyään katsotaan, että tällaista kuvausta ei voida antaa elävästä organismista. Tästä joh- tuen on kasvilajikkeille kehitetty oma, patenttia vastaa- va, UPOV-sopimuksessa määritelty suoja. Yhtenä biotekniikan lupaavimpana sovelluksena pide- tään kasvintuotantoa. Kasvinjalostuksessa käytettävien bioteknisten jalostusmenetelmien katsotaan täyttävän pa- tentoinnille asetetut ehdot paremmin kuin perinteisten me- netelmien. Tämän perusteella on vaadittu patenttisuojan laajentamista koskemaan myös uusia kasvilajikkeita. Euroopan patenttisopimuksen piirissä oikeuskäytäntö on vielä vakiintumaton. Lainsäädäntöprosessivaikuttaa niin hitaalta, että nykyistä lakia joudutaantulkitsemaan mahdollisimman väljästi. Tällä hetkellä kasvimateriaali näyttää patentoimiskelpoiselta, mutta asiaa selventävät ennakkotapaukset puuttuvat. Yhdysvalloissa patenttilainsäädäntö on mukautunut biotekniikan kehitykseen paremmin kuin Euroopassa. Yh- dysvalloissa on mahdollista suojata kasveja tuotepaten- teilla ja valita suojan muodoksi patentti tai jalostajan- oikeudet. UPOV;in tarjoaman kasvilajikesuojan pahimpina heik- kouksina pidetään jatkojalostusoikeutta ja viljelijän oikeutta käyttää satoaan siemenenä. Näiden oikeuksien katsotaan tarjoavan mahdollisuuksia suojan kiertämiseen. Kasvinjalostustyötä tekevät yritykset ja teollisuusmai- ta edustavat järjestöt suosittelevat suojan parantamista. Parantuneen suojan katsotaan vauhdittavan alan kehi- tystä. Sitävastoin viljelijät ja kehitysmaiden edustajat ovat kasvilajikesuojan parantamista vastaan. Viljelijät pelkää- vät siementen kallistumista ja liiallista riippuvuutta sie- mentuottajasta. Kehitysmaissa epäillään monikansallis- ten yritysten vaikutusvallan kasvavan parantuneen laji- kesuojan myötä. 414